RecallDepth
Class II Terminated

MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30

This recall has been terminated (originally issued August 14, 2013).

Company
Astrazeneca Pharmaceuticals Lp
Recall Initiated
June 21, 2013
Posted
August 14, 2013
Recall Number
D-840-2013
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
81,900 total vials
Firm Location
Wilmington, DE, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of Precipitate; potential for incomplete constitution upon addition of diluent.

Distribution

USA and Puerto Rico

Lot / Code Info

NDC 0310-321-30, lot JX109, expiration 2/2015; lot JY042, expiration 2/2015

More recalls by Astrazeneca Pharmaceuticals Lp

View all recalls by this company →

Other recent Class II Drug recalls